Furthermore, IGH::DUX4 triggers the aberrant transcripts such as CLEC12Aalt and C6orf89alt, which is identified in B‐ALL patients along with the secondary leukaemogenic hit ERGalt.2 Here, DUX4 is linked to acute lymphoblastic leukemia.